209 related articles for article (PubMed ID: 15767830)
1. Current trials of interventions to prevent radiocontrast-induced nephropathy.
Asif A; Garces G; Preston RA; Roth D
Am J Ther; 2005; 12(2):127-32. PubMed ID: 15767830
[TBL] [Abstract][Full Text] [Related]
2. Prevention of radiocontrast-induced nephropathy.
Asif A; Epstein M
Am J Kidney Dis; 2004 Jul; 44(1):12-24. PubMed ID: 15211433
[TBL] [Abstract][Full Text] [Related]
3. Recent advances in the prevention of radiocontrast-induced nephropathy.
Marenzi G; Bartorelli AL
Curr Opin Crit Care; 2004 Dec; 10(6):505-9. PubMed ID: 15616393
[TBL] [Abstract][Full Text] [Related]
4. Radiocontrast-induced nephropathy.
Asif A; Preston RA; Roth D
Am J Ther; 2003; 10(2):137-47. PubMed ID: 12629594
[TBL] [Abstract][Full Text] [Related]
5. Dopamine-1 receptor agonist: renal effects and its potential role in the management of radiocontrast-induced nephropathy.
Asif A; Epstein DL; Epstein M
J Clin Pharmacol; 2004 Dec; 44(12):1342-51. PubMed ID: 15545304
[TBL] [Abstract][Full Text] [Related]
6. Radiocontrast-induced acute renal failure.
Weisbord SD; Palevsky PM
J Intensive Care Med; 2005; 20(2):63-75. PubMed ID: 15855219
[TBL] [Abstract][Full Text] [Related]
7. [Contrast induced nephropathy].
Hörl WH
Wien Klin Wochenschr; 2009; 121(1-2):15-32. PubMed ID: 19263010
[TBL] [Abstract][Full Text] [Related]
8. Use of isotonic sodium bicarbonate to prevent radiocontrast nephropathy in patients with mild pre-existing renal impairment: a meta-analysis.
Ho KM; Morgan DJ
Anaesth Intensive Care; 2008 Sep; 36(5):646-53. PubMed ID: 18853581
[TBL] [Abstract][Full Text] [Related]
9. Clinical and experimental evidence for prevention of acute renal failure induced by radiographic contrast media.
Itoh Y; Yano T; Sendo T; Oishi R
J Pharmacol Sci; 2005 Apr; 97(4):473-88. PubMed ID: 15821342
[TBL] [Abstract][Full Text] [Related]
10. Prophylaxis of iodinated contrast media-induced nephropathy: a pharmacological point of view.
Idé JM; Lancelot E; Pines E; Corot C
Invest Radiol; 2004 Mar; 39(3):155-70. PubMed ID: 15076008
[TBL] [Abstract][Full Text] [Related]
11. [Nephropathy caused by radiocontrast media].
Kolarz M; Sułowicz W
Przegl Lek; 2005; 62(5):292-8. PubMed ID: 16334535
[TBL] [Abstract][Full Text] [Related]
12. Radiocontrast-induced acute renal failure: allocations and outcomes.
Mehran R; Ashby DT
Rev Cardiovasc Med; 2001; 2 Suppl 1():S9-13. PubMed ID: 12439362
[TBL] [Abstract][Full Text] [Related]
13. Pathophysiology of radiocontrast nephropathy and use of fenoldopam for its prevention.
Mathur VS
Rev Cardiovasc Med; 2001; 2 Suppl 1():S4-8. PubMed ID: 12439361
[TBL] [Abstract][Full Text] [Related]
14. Clinical experience with the use of fenoldopam for prevention of radiocontrast nephropathy in high-risk patients.
Madyoon H
Rev Cardiovasc Med; 2001; 2 Suppl 1():S26-30. PubMed ID: 12439365
[TBL] [Abstract][Full Text] [Related]
15. Design and rationale of CONTRAST--a prospective, randomized, placebo-controlled trial of fenoldopam mesylate for the prevention of radiocontrast nephropathy.
Stone GW; Tumlin JA; Madyoon H; Lepor NE; McCullough PA; Mathur VS; Murray PT; O'Neill WW
Rev Cardiovasc Med; 2001; 2 Suppl 1():S31-6. PubMed ID: 12439366
[TBL] [Abstract][Full Text] [Related]
16. Fenoldopam and N-acetylcysteine for the prevention of radiographic contrast material-induced nephropathy: a review.
Walker PD; Brokering KL; Theobald JC
Pharmacotherapy; 2003 Dec; 23(12):1617-26. PubMed ID: 14695041
[TBL] [Abstract][Full Text] [Related]
17. Managing the high-risk patient: experience with fenoldopam, a selective dopamine receptor agonist, in prevention of radiocontrast nephropathy during percutaneous coronary intervention.
Kini AA; Sharma SK
Rev Cardiovasc Med; 2001; 2 Suppl 1():S19-25. PubMed ID: 12439364
[TBL] [Abstract][Full Text] [Related]
18. A review of contemporary prevention strategies for radiocontrast nephropathy: a focus on fenoldopam and N-acetylcysteine.
Lepor NE
Rev Cardiovasc Med; 2003; 4 Suppl 1():S15-20. PubMed ID: 12556733
[TBL] [Abstract][Full Text] [Related]
19. Acetylcysteine for prevention of contrast nephropathy: meta-analysis.
Birck R; Krzossok S; Markowetz F; Schnülle P; van der Woude FJ; Braun C
Lancet; 2003 Aug; 362(9384):598-603. PubMed ID: 12944058
[TBL] [Abstract][Full Text] [Related]
20. Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
van den Berk G; Tonino S; de Fijter C; Smit W; Schultz MJ
Crit Care; 2005 Aug; 9(4):361-70. PubMed ID: 16137385
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
